TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $10,000 | -100.0% | 11,000 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $26,105,000 | -16.9% | 23,840,000 | -9.5% | 0.00% | -25.0% |
| Q3 2016 | $31,427,000 | -15.8% | 26,340,000 | -11.5% | 0.00% | -20.0% |
| Q2 2016 | $37,306,000 | +136.2% | 29,770,000 | +145.2% | 0.01% | +150.0% |
| Q1 2016 | $15,797,000 | -15.0% | 12,140,000 | +1.9% | 0.00% | -33.3% |
| Q4 2015 | $18,594,000 | +121.8% | 11,910,000 | +92.7% | 0.00% | +200.0% |
| Q3 2015 | $8,382,000 | +25300.0% | 6,180,000 | +19212.5% | 0.00% | – |
| Q2 2013 | $33,000 | – | 32,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 20,000,000 | $17,675,000 | 25.38% |
| INCOME RESEARCH & MANAGEMENT | 23,109,000 | $20,278,000 | 5.29% |
| Fore Capital, LLC | 5,000,000 | $4,430,000 | 1.71% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 20,000,000 | $17,603,000 | 0.74% |
| ARISTEIA CAPITAL, L.L.C. | 18,500,000 | $16,361,000 | 0.70% |
| ZAZOVE ASSOCIATES LLC | 11,153,000 | $9,843,000 | 0.58% |
| BASSO CAPITAL MANAGEMENT, L.P. | 3,600,000 | $3,182,000 | 0.52% |
| CSS LLC/IL | 10,450,000 | $9,240,000 | 0.45% |
| Lombard Odier Asset Management (Europe) Ltd | 7,950,000 | $7,038,000 | 0.44% |
| Wellesley Asset Management | 6,740 | $5,948,000 | 0.31% |